Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Health Catalyst
HCAT
$160M
| $183K | ﹤0.01% |
19,775
-37
| -0.2% | -$302 |
|
2452
Planet Labs
PL
$6.94B
| $179K | ﹤0.01% |
72,461
-84
| -0.1% | -$199 |
|
|
SHYF
2453
DELISTED
The Shyft Group
SHYF
| $177K | ﹤0.01% |
14,509
-29
| -0.2% | -$354 |
|
|
BRY
2454
DELISTED
Berry Corp
BRY
| $177K | ﹤0.01% |
25,167
-60
| -0.2% | -$450 |
|
2455
LSB Industries
LXU
$824M
| $177K | ﹤0.01% |
18,964
-66
| -0.3% | -$602 |
|
2456
Mercer International
MERC
$40.5M
| $177K | ﹤0.01% |
18,650
| – | – |
|
|
CDMO
2457
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $176K | ﹤0.01% |
27,222
-51
| -0.2% | -$329 |
|
2458
ARKO Corp
ARKO
$868M
| $175K | ﹤0.01% |
21,192
-68
| -0.3% | -$521 |
|
2459
Novavax
NVAX
$1.21B
| $173K | ﹤0.01% |
36,066
-109
| -0.3% | -$667 |
|
2460
VTEX
VTEX
$767M
| $172K | ﹤0.01% |
25,053
-1,792
| -7% | -$10.9K |
|
|
LGTY
2461
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $169K | ﹤0.01% |
14,923
-27
| -0.2% | -$290 |
|
|
NAPA
2462
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $167K | ﹤0.01% |
16,973
-43
| -0.3% | -$434 |
|
2463
Pennant Group
PNTG
$1.43B
| $166K | ﹤0.01% |
11,918
-23
| -0.2% | -$287 |
|
2464
Definitive Healthcare
DH
$77M
| $166K | ﹤0.01% |
16,688
+17
| +0.1% | +$133 |
|
2465
Community Health Systems
CYH
$382M
| $163K | ﹤0.01% |
52,126
-106
| -0.2% | -$286 |
|
2466
SiriusXM
SIRI
$11B
| $163K | ﹤0.01% |
2,971
-50
| -2% | -$2.4K |
|
|
SLGC
2467
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $163K | ﹤0.01% |
64,395
-119
| -0.2% | -$277 |
|
2468
Lindblad Expeditions
LIND
$1.95B
| $162K | ﹤0.01% |
14,349
-31
| -0.2% | -$240 |
|
2469
SmartRent
SMRT
$192M
| $161K | ﹤0.01% |
50,433
-108
| -0.2% | -$315 |
|
2470
Harrow
HROW
$1.44B
| $161K | ﹤0.01% |
14,364
-29
| -0.2% | -$343 |
|
|
HRT
2471
DELISTED
HireRight Holdings Corporation
HRT
| $160K | ﹤0.01% |
11,917
-25
| -0.2% | -$283 |
|
|
AMPS
2472
DELISTED
Altus Power
AMPS
| $157K | ﹤0.01% |
23,033
-56
| -0.2% | -$303 |
|
|
ORGN
2473
DELISTED
Origin Materials
ORGN
| $157K | ﹤0.01% |
6,256
+504
| +9% | +$14.5K |
|
|
EWCZ
2474
DELISTED
European Wax Center
EWCZ
| $155K | ﹤0.01% |
11,416
-24
| -0.2% | -$348 |
|
2475
SoundHound AI
SOUN
$2.48B
| $154K | ﹤0.01% |
72,814
+31
| +0% | +$61 |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.